Natalia Kozak-Muiznieks, PhD
Microbiologist Centers for Disease Control and Prevention Division of Bacterial Diseases May 18, 2015
Legionella and Public Health
National Center for Immunization & Respiratory Diseases Division of Bacterial Diseases
Legionella and Public Health Natalia Kozak-Muiznieks, PhD - - PowerPoint PPT Presentation
Legionella and Public Health Natalia Kozak-Muiznieks, PhD Microbiologist Centers for Disease Control and Prevention Division of Bacterial Diseases May 18, 2015 National Center for Immunization & Respiratory Diseases Division of Bacterial
Natalia Kozak-Muiznieks, PhD
Microbiologist Centers for Disease Control and Prevention Division of Bacterial Diseases May 18, 2015
National Center for Immunization & Respiratory Diseases Division of Bacterial Diseases
Holland/Özel, Robert Koch-Institut
Celsius Fahrenheit
25 77 35 95 42 108 45 113 55 131 Dormant Growth Death
secreted slime surface free-floating bacteria biofilm-associated bacteria
Water Supplies Amplification Aerosolization Host Transmission
Incidence of Legionellosis—United States, 1998-2011*
0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Incidence per 100,000 pop. Year
Average Annual Rates of Reported Legionellosis Cases per 100,000 Population, NNDSS, 2000-2009
< 0.50 0.50 - 1.00 1.01 - 1.50 1.51 - 2.00 2.01 - 2.50 2.51 - 3.00
Note: Alaska and Hawaii are part of the Pacific Reporting Area
1 2 3 4 5 6
8/31/2013 9/30/2013
Case Count Symptom Onset Date 1 2 3 4
Number of cases Illness onset
Legionella Environmental Assessment
humidifiers, etc.)
machines, etc.)
(whirlpool spas, fountains, etc.)
BCYE BCYE without L-cysteine
5-8 hours - Initial sample processing Up to 7 days - Incubation Up to 2 days - Confirming Legionella isolates to genus level
isolates
species, serogroups and genotypes
60 species of Legionellae > 90% of the isolates associated with Legionnaires’ disease - L. pneumophila 79% of cases are due to L. pneumophila serogroup 1 (Lp1) majority of Lp1 clinical isolates reacts with MAb2
Virulent genotypes 17 serogroups of
Lp6, Lp5, Lp8 are also frequent “offenders” MAb panel contains 7 monoclonal antibodies There are > 2000 sequence types
STs are responsible for the majority of sporadic LD cases
hyperchlorination)
months
additional 3 months
VA Hospital
Background:
Investigation
Conclusions:
Las Vegas Condominiums
Background:
Investigation
Conclusions:
GA Resort
Background:
chalets
Investigation:
disinfectant or filtration
system in reasonable details
Conclusion:
For more information please contact Centers for Disease Control and Prevention
1600 Clifton Road NE, Atlanta, GA 30333 Telephone, 1-800-CDC-INFO (232-4636)/TTY: 1-888-232-6348 E-mail: cdcinfo@cdc.gov Web: www.cdc.gov
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
National Center for Immunization & Respiratory Diseases Division of Bacterial Diseases
Natalia Kozak-Muiznieks Centers for Disease Control and Prevention 1600 Clifton Rd NE MS G03 Atlanta, GA 30333 Phone (404) 639-2305